CNTB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Connect Biopharma Holdings Ltd (CNTB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to support an immediate purchase. Holding off for now is recommended.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 41.176, showing no clear signal. Moving averages are converging, suggesting indecision in price movement. The current price is below the pivot level (2.59), with support at 2.399 and resistance at 2.781.
NULL identified. No recent news or significant insider/hedge fund activity. Congress trading data is also absent.
The MACD and technical indicators suggest bearish momentum.
In Q3 2025, revenue dropped significantly to $16,000 (-98.69% YoY). However, net income improved to -$17.2M (+33.58% YoY), and EPS increased to -0.31 (+34.78% YoY). Gross margin remained stable at 100%. Overall, financial performance is weak, with limited growth prospects.
No recent analyst ratings or price target changes available.
